Vehicle-treated Rac2 −/− BMDM showed a trend toward lower cholesterol ester accumulation relative to vehicle-treated WT BMDM, although this difference was not significant (Fig. 3 e).
← all excerpts
The neurorepellent, Slit2, prevents macrophage lipid loading by inhibiting CD36-dependent binding and internalization of oxidized low-density lipoprotein.
1
—
—